Guided Antithrombotic Therapy: Current Status and Future Research Direction Report on a National Heart, Lung and Blood Institute Working Group

CIRCULATION

LIPPINCOTT WILLIAMS & WILKINS

1. National Institutes of Health [HL57506]
2. Bristol Myers Squibb
3. Sanofi-Aventis
4. Eli Lilly Co
5. Daiichi Sankyo, Inc.
6. Medicines Company
7. Portola
8. Novartis
9. Medicure
10. Accumetrics
11. Arena Pharmaceuticals
12. Abbott Vascular
13. Astra Zeneca
14. Merck
15. Evolva
16. GlaxoSmithKline
17. Otsuka
18. Schering-Plough
19. Astra-Zeneca
20. Eisai
21. Amarin
22. Ethicon
23. Medtronic
24. Sanofi Aventis
25. Amylin
26. Johnson & Johnson (Scios)
27. Novartis Pharma
28. Schering Plough
29. Bristol-Myers Squibb Foundation
30. Aterovax
31. Bayer
32. Roche
33. Lilly
34. Duke Clinical Research Institute
35. Eli Lilly
36. Daiichi-Sanko
37. Edwards Lifesciences
38. Boston Scientific
39. Pfizer
40. Biotronik
41. Medco Research Institute
42. NIH [PO1-HL046703]
43. Brigham and Women's Hospital from Eli Lilly
44. Daiichi Sankyo
45. Johnson Johnson
46. Bristol-Myers Squibb/Sanofi-Aventis
47. GLSynthesis
48. Takeda
49. Quest Diagnostics
50. Brigham
51. Women's Hospital from Abbott
52. Amgen
53. AstraZeneca
54. Bristol-Myers Squibb
55. Daiichi-Sankyo
56. Nanosphere
57. Bayer Pharmaceuticals
58. [HL 19278]
59. [CTSA UL1 TR000043]